Results 261 to 270 of about 118,307 (297)
Current Advances of Antibacterial Biomaterials for Bone Regeneration
Effective treatment of infectious bone defects requires not only robust bone regeneration, but also the elimination of bacterial infection. This review highlights current cutting‐edge concepts and innovations in synthetic bone repair biomaterials and antibacterial bone repair materials, aiming to promote clinical translation and inspire broader ...
Xueping Kong+3 more
wiley +1 more source
A multi‐functional photo‐enzymatic nanoreactor HRP@Fe‐NU‐1003 is developed through co‐immobilization of horseradish peroxidase and FeCl2 on a photosensitive metal–organic frameworks NU‐1003. This material showcases remarkable sensitivity and efficacy in both detecting and subsequently photo‐degrading chloramphenicol residues in food products.
Lu Ran+5 more
wiley +1 more source
A Red Skin in the Setting of Chickenpox: A Rare Report of Eosin Toxicity
ABSTRACT Eosin Yellowish (Eosin‐Y) is an effective treatment option for a range of dermatological conditions. It is crucial to carefully identify patients presenting systemic adverse reactions related to topical aqueous Eosin‐Y overuse and to monitor them closely during short‐term use to prevent severe complications.
Bahareh Abtahi‐Naeini+5 more
wiley +1 more source
ABSTRACT Twin gastroschisis pregnancies poses challenges in prenatal diagnosis especially for multiple pregnancies among radiologists, and therefore impacts postnatal care by neonatologists and pediatric surgeons. This case emphasizes the successful management of twin babies born with gastroschisis, highligting the role of sutureless abdominal closure ...
Rajabu Athumani Bakari+9 more
wiley +1 more source
Butyrate, a short‐chain fatty acid (SCFA) derived from dietary fibers, selectively inhibits human mast cell activation by targeting transcription start sites (TSS) and super‐enhancers regulating key mast cell genes. Local histone hypoacetylation induced by butyrate likely drives transcriptional suppression and reduced degranulation, providing new ...
Jelle Folkerts+4 more
wiley +1 more source
ABSTRACT Background and Aims Pulmonary hydatid cysts (PHC), resulting from infection by Echinococcus granulosus larvae, represent a substantial health risk in livestock‐raising areas, often causing respiratory symptoms and even death. The primary treatment for PHC involves surgical excision, either through open thoracotomy or video‐assisted ...
Fahmi H. Kakamad
wiley +1 more source
ABSTRACT Background and Aims Multidrug‐resistant (MDR) pathogens, particularly members of the ESKAPE group and Escherichia coli (collectively referred to as ESKAPEEc), are major contributors to bloodstream infections (BSIs) and pose significant treatment challenges.
Bakoena A. Hetsa+5 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drug Intelligence & Clinical Pharmacy, 1987
Ciprofloxacin is a new fluorinated quinolone antibiotic with high activity against a wide spectrum of gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus, Enterobacteriaceae, and Pseudomonas aeruginosa. Clinical trials using the oral preparation of ciprofloxacin have demonstrated its effectiveness in a wide ...
D K, Terp, M J, Rybak
openaire +2 more sources
Ciprofloxacin is a new fluorinated quinolone antibiotic with high activity against a wide spectrum of gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus, Enterobacteriaceae, and Pseudomonas aeruginosa. Clinical trials using the oral preparation of ciprofloxacin have demonstrated its effectiveness in a wide ...
D K, Terp, M J, Rybak
openaire +2 more sources
Pharmacokinetics of ciprofloxacin
Infection, 1988The fluorination of piperazinyl substituted quinolones has led to an interesting development of a series of new broad spectrum antibacterial agents that may be administered orally as well as parenterally and are well tolerated. Norfloxacin was an early compound, later followed by ciprofloxacin, enoxacin, ofloxacin and pefloxacin.
R. Rohwedder, T. Bergan, Axel Dalhoff
openaire +3 more sources